Title: 139MO Prognostic significance of the mechanism of inflammatory markers in advanced renal cell carcinoma patients treated with nivolumab plus ipilimumab
Abstract: The discovery of a useful biomarker for advanced renal cell carcinoma (RCC) treated with immune checkpoint inhibitors is expected. In this study, we aimed to investigate whether the mechanism of inflammatory makers is associated with the efficacy of nivolumab plus ipilimumab.